Addendum to the note for guidance on antiarrhythmics on atrial fibrillation and atrial flutter
| Current effective version |
|
| Reference number | CHMP/EWP/213056/2010 |
| Published | 20/09/2010 |
| Effective from | 01/02/2011 |
| Keywords | Atrial fibrillation, rhythm control, rate control, cardioversion |
| Description | This document is an addendum to the note for guidance on antiarrhythmics. It provides guidance for the evaluation of new medicinal products or drugs used in the antiarrhythmic treatment of atrial fibrillation. |
Document history
First version Current version |
| In operation: 01/12/2011–present
Published: 24/07/2008
Published: 21/09/2006 |
Related content
- Directive 2001/83/EC
- ICH E1 Extent of population exposure to assess clinical safety
- ICH E4 Dose-response information to support drug registration
- ICH E8 General considerations for clinical trials
- ICH E9 Statistical principles for clinical trials
- ICH E10 Choice of control group in clinical trials
- Investigation of drug interactions